Technology

Apple Watch Series 12 and Ultra 4 Enter Late-Stage Testing as Apple Holds Back Major Redesign

Martin HollowayPublished 5d ago4 min readBased on 7 sources
Reading level
Apple Watch Series 12 and Ultra 4 Enter Late-Stage Testing as Apple Holds Back Major Redesign

Apple's next-generation Apple Watch models — the Series 12 in both Wi-Fi and cellular variants and the Apple Watch Ultra 4 — are in late-stage testing as of late July 2026, according to reporting from Bloomberg's Mark Gurman in his Power On newsletter on July 26, 2026, corroborated by Engadget.

The 2026 models will not introduce a major design overhaul. Apple is instead directing the update cycle toward health and fitness-tracking improvements, spec bumps, and new silicon. The last significant processor change for the Apple Watch was the S9 chip, introduced in 2023 with the Series 9; the Series 10 and Series 11 that followed iterated on that platform rather than replacing it. A new chip generation in the Series 12 would break that three-year cadence of carry-over silicon, though Apple has not publicly confirmed any such upgrade.

The Apple Watch SE will not receive a refresh in 2026. The SE 3 launched in 2025, and Apple appears to be holding that budget-tier product on a longer update interval than its flagship line.

A more substantial rethink of the Apple Watch's industrial design is expected in a year or two, pointing to 2027 or 2028 as the window for a form-factor change. This aligns with a report from 9to5Mac on June 30, 2026, which cited an unnamed leaker claiming a "major overhaul" was coming to a future model year. That same report specified the Apple Watch Ultra 4 would feature a "major redesign" and significant sensor changes. Gurman's July 26 newsletter, published nearly a month later, does not echo the claim of a Ultra 4 redesign for 2026, instead placing the broader design rethink further out. The most recent reporting should be treated as the authoritative version: the 2026 Ultra 4 appears to be an iterative update, with the larger redesign deferred.

Apple's newsroom contains no press release, announcement, or official comment regarding the Series 12 or Ultra 4 as of the search date, which is consistent with Apple's typical pattern of confirming new watch models at its September event.

The product cadence provides useful context. Apple introduced the Watch Series 10 in September 2024 in 42mm and 46mm sizes across jet black, rose gold, and silver aluminum finishes. The Series 11 followed in September 2025, debuting what Apple called "groundbreaking health insights," including notifications for signs of chronic high blood pressure. The Ultra 3 also arrived in September 2025. If Apple maintains its September launch cadence, the Series 12 and Ultra 4 would be expected to debut in September 2026.

One long-rumored capability remains in active development: non-invasive blood sugar detection. Apple is still working on the feature, which would use optical sensors to measure glucose levels through the skin without a finger prick. Apple was reportedly developing blood glucose monitoring software as early as 2024, and the project appears to still be in the research pipeline rather than near-term productization. Non-invasive glucose monitoring has been a sustained engineering challenge across the wearables industry; Apple's continued investment signals it has not been deprioritized, but the feature's absence from the confirmed 2026 health improvements suggests it is not ready for shipping hardware.

The broader context here is that Apple's watch strategy in 2026 is one of consolidation rather than spectacle. After the Series 11's blood pressure notifications, a genuinely new health capability, the Series 12 and Ultra 4 appear positioned as refinement releases: better sensors, a likely new S-series chip, and fitness-tracking depth, all inside the existing chassis. This is the Apple product rhythm that anyone who tracked the iPhone's mid-cycle years will recognize. The major industrial redesign, along with potentially transformative sensor additions like glucose monitoring, is being deferred to 2027 or beyond.

For developers working in the watchOS ecosystem, the near-term signal is continuity. No new form factor means no new display dimensions or input paradigms to design around. Health and fitness API expansion is the more likely area of change, and even there the scope appears measured. The more disruptive developer story, if and when it arrives, will accompany the redesign, but that is a year or more out.